MR antagonists are a class of drugs that effectively lower blood pressure and slow the progression of kidney disease by inhibiting excessive activation of aldosterone on MR, thereby reducing oxidative stress, inflammation, fibrosis, and vascular remodeling [9]. The gene discussed is NR3C2; the disease is kidney disorder.